Wittycell wittycell.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Wittycell, set up in 2005 as a spin-off from the French Institute Jean Godinot, is a biotechnology company developing novel therapeutic and prophylactic vaccine adjuvants in the field of oncology and infectious diseases.

Wittycell, set up in 2005 as a spin-off from the French Institute Jean Godinot, is a biotechnology company developing novel therapeutic and prophylactic vaccine adjuvants in the field of oncology and infectious diseases.

Company (Alive / Active)

Phone:

Fax:




France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Wittycell $0M Mar 25, 2011

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Wittycell Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Increase of immune response and targeting by antigens and/or drug linkage Nov 07, 2008 Feb 04, 2014 Patent
Compositions for and methods of enhancing the immune response to antigens Dec 05, 2008 Jul 03, 2012 Patent
Compositions for and methods of enhancing the immune response to antigens Dec 05, 2008 Jun 26, 2012 Patent